abstral 200 mikrog resoribletti
kyowa kirin holdings b.v. - fentanyl citrate - resoribletti - 200 mikrog - fentanyyli
abstral 300 mikrog resoribletti
kyowa kirin holdings b.v. - fentanyl citrate - resoribletti - 300 mikrog - fentanyyli
abstral 400 mikrog resoribletti
kyowa kirin holdings b.v. - fentanyl citrate - resoribletti - 400 mikrog - fentanyyli
abstral 600 mikrog resoribletti
kyowa kirin holdings b.v. - fentanyl citrate - resoribletti - 600 mikrog - fentanyyli
abstral 800 mikrog resoribletti
kyowa kirin holdings b.v. - fentanyl citrate - resoribletti - 800 mikrog - fentanyyli
minjuvi
incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - antineoplastiset aineet - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).
iclusig
incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. katso kohdat 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.
sunosi
atnahs pharma netherlands b.v. - solriamfetol hydrochloride - narcolepsy; sleep apnea, obstructive - psychoanaleptics, - sunosi on tarkoitettu parantamaan valveillaolon ja vähentää liiallista päiväväsymystä aikuisilla narkolepsiapotilailla (tai ilman katapleksiaa). sunosi on tarkoitettu parantamaan valveillaolon ja vähentää liiallista päiväväsymystä (eds) aikuisilla potilailla, joilla on obstruktiivinen uniapnea (osa), jonka eds ei ole tyydyttävästi käsitelty ensisijainen osa hoitoa, kuten jatkuva positiivinen hengitysteiden paine (cpap).
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - muut hermoston huumeet - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
abstral 50 mikrog resoribletti
prostrakan ltd. - fentanyli citras - resoribletti - 50 mikrog - fentanyyli